Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Activz is a health and wellness company that focuses on the field of epigenetics and cellular health. The company develops and markets nutraceutical products designed to activate specific genetic pathways, such as Nrf2, to combat oxidative stress and inflammation. Their core product line includes GNMX, LINQ, and OPTIMEND, which target cellular defense, gut health, and joint support, respectively. Activz utilizes a direct-to-consumer multi-level marketing model to distribute its products globally, with a significant presence in the United States and Latin America. The company emphasizes a science-based approach to supplementation, aiming to optimize gene expression for improved metabolic and immune function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Activz Global.